Sec Form 3 Filing - Alaska Permanent Fund Corp @ Codiak BioSciences, Inc. - 2020-10-13

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Alaska Permanent Fund Corp 2. Issuer Name and Ticker or Trading Symbol Codiak BioSciences, Inc. [ CDAK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 801 WEST 10TH STREET, SUITE 302 3. Date of Earliest Transaction (MM/DD/YY) 10/13/2020 (Street) JUNEAU, AK99801 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.0001 per share 63,963 I See footnotes ( 1 ) ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A redeemable convertible preferred stock ( 3 ) ( 4 ) ( 3 )( 4 ) ( 3 )( 4 ) Common St ock 2,616,093 ( 3 ) ( 4 ) I See footnotes ( 2 ) ( 5 ) Series B redeemable convertible preferred stock ( 3 ) ( 4 ) ( 3 )( 4 ) ( 3 )( 4 ) Common Stock 467,541 ( 3 ) ( 4 ) I See footnote ( 6 ) Series B redeemable convertible preferred stock ( 3 ) ( 4 ) ( 3 )( 4 ) ( 3 )( 4 ) Common Stock 748,061 ( 3 ) ( 4 ) I See footnotes ( 2 ) ( 5 ) Series C redeemable convertible preferred stock ( 3 ) ( 4 ) ( 3 )( 4 ) ( 3 )( 4 ) Common Stock 191,992 ( 3 ) ( 4 ) I See footnote ( 6 ) Series C redeemable convertible preferred stock ( 3 ) ( 4 ) ( 3 )( 4 ) ( 3 )( 4 ) Common Stock 191,992 ( 3 ) ( 4 ) I See footnotes ( 2 ) ( 7 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Alaska Permanent Fund Corp 801 WEST 10TH STREET SUITE 302 JUNEAU, AK99801 X Signatures /s/ Angela Rodell, Chief Executive Officer 10/13/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares are held by ARCH Venture Fund VIII, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII, L.P.. ( 2 )The Reporting Person disclaims beneficial ownership of the securities, except to the extent of its pecuniary interest therein and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. ( 3 )All shares of Series A redeemable convertible preferred stock, par value $0.0001 per share, Series B redeemable convertible preferred stock, par value $0.0001 per share, and Series C redeemable convertible preferred stock, par value $0.0001 per share, have no expiration date and will automatically convert into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering ("IPO"). Each share of Series A Preferred Stock is convertible into Common Stock on a 1-for-7.8170 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO. ( 4 )Each share of Series B Preferred Stock is convertible into Common Stock on an approximately 1-for-7.1295 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO. Each share of Series C Preferred Stock is convertible into Common Stock on an approximately 1-for-6.8758 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO. ( 5 )The shares are held by ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in each of ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P.. ( 6 )The shares are held by Yukon Investors, LLC. The Reporting Person holds an interest in Yukon Investors, LLC. ( 7 )The shares are held by ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII Overage, L.P..

Remarks: The Reporting Person is the Alaska Permanent Fund Corporation, acting for and on behalf of the funds which the Alaska Permanent Fund Corporation is designated by Alaska Statutes 37.13 to manage and invest.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.